Clinical Trial Update: Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Optic Nerve Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial is evaluating autologous bone marrow–derived cells for optic nerve disease (optic atrophy) sponsored by Chaitanya Hospital, Pun…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Optic Atrophy

Drugs mentioned

• bone marrow derived autologous cells

Snippet

Sponsor: Chaitanya Hospital, Pune | Conditions: Optic Atrophy | Phase 1, Phase 2 | Status: UNKNOWN